Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1983 2
1985 1
1986 3
1987 2
1988 5
1989 4
1990 2
1991 1
1992 3
1994 2
1995 2
1996 3
1997 3
1998 2
1999 6
2000 4
2001 1
2002 3
2003 4
2004 6
2005 6
2006 2
2007 4
2008 7
2009 7
2010 6
2011 5
2012 7
2013 6
2014 7
2015 6
2016 7
2017 6
2018 9
2019 6
2020 7
2021 7
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Results by year
Filters applied: . Clear all
Page 1
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
Kudo M, Matilla A, Santoro A, Melero I, Gracián AC, Acosta-Rivera M, Choo SP, El-Khoueiry AB, Kuromatsu R, El-Rayes B, Numata K, Itoh Y, Di Costanzo F, Crysler O, Reig M, Shen Y, Neely J, Tschaika M, Wisniewski T, Sangro B. Kudo M, et al. Among authors: di costanzo f. J Hepatol. 2021 Sep;75(3):600-609. doi: 10.1016/j.jhep.2021.04.047. Epub 2021 May 26. J Hepatol. 2021. PMID: 34051329 Free article.
Lunghi A, Antonuzzo L, Laffi A, Giommoni E, Di Costanzo F. Lunghi A, et al. Among authors: di costanzo f. J Natl Cancer Inst. 2016 Jul 7;108(9):djw156. doi: 10.1093/jnci/djw156. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27390046 No abstract available.
Prostaglandins in Marine Organisms: A Review.
Di Costanzo F, Di Dato V, Ianora A, Romano G. Di Costanzo F, et al. Mar Drugs. 2019 Jul 23;17(7):428. doi: 10.3390/md17070428. Mar Drugs. 2019. PMID: 31340503 Free PMC article. Review.
Bevacizumab in non-small cell lung cancer.
Di Costanzo F, Mazzoni F, Micol Mela M, Antonuzzo L, Checcacci D, Saggese M, Di Costanzo F. Di Costanzo F, et al. Drugs. 2008;68(6):737-46. doi: 10.2165/00003495-200868060-00002. Drugs. 2008. PMID: 18416583 Review.
Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review.
Servetto A, Salomone F, Di Costanzo F, Iuliano R, Marandino L, Napolitano F, Santaniello A, De Placido P, De Placido S, Di Maio M, Formisano L, Bianco R. Servetto A, et al. Among authors: di costanzo f. Crit Rev Oncol Hematol. 2022 Apr;172:103649. doi: 10.1016/j.critrevonc.2022.103649. Epub 2022 Mar 5. Crit Rev Oncol Hematol. 2022. PMID: 35259486 Review.
The Italian Rare Pancreatic Exocrine Cancer Initiative.
Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N. Brunetti O, et al. Among authors: di costanzo f. Tumori. 2019 Aug;105(4):353-358. doi: 10.1177/0300891619839461. Epub 2019 Apr 9. Tumori. 2019. PMID: 30967031 Free article.
159 results